Biogen Idec, Inc. (Massachusetts) Reports Second Quarter 2011 Results

July 26, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB), a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced its second quarter 2011 results.

Twitter
LinkedIn
Facebook
Email
Print

Earnings

Biogen